A. Morice (Cottingham, United Kingdom)
The association between objective CT measures of bronchiectasis and health-related quality of life in COPD
A. Diaz, J. Ross, G. Washko, R. San Jose Estepar (Boston, United States Of America)
|  |
Oxidative stress and systemic inflammation in different COPD phenotypes
P. Ceriana, G. Brunetti, T. Coccini, E. Roda, A. Spanevello (Pavia, Tradate, Italy)
|  |
Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score
F. Diamantea, K. Kostikas, K. Bartziokas, F. Karakontaki, S. Tsikrika, S. Pouriki, V. Polychronopoulos, N. Karagiannidis, A. Chaniotou, A. Papaioannou (Athens, Greece)
| |
Altered P2 receptor expression profile in sputum cells of patients with COPD
Z. Lazar, K. Ayata, W. Meschede, I. Horvath, M. Idzko (Freiburg, Germany; Budapest, Hungary)
| |
COPD telemonitoring: Analysis of hospital admissions
M. Crooks, G. Hamad, M. Cosgrove, C. Alexander, A. Morice (Hull, United Kingdom)
| |
Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD
M. Brusse-Keizer, M. Klatte, M. Zuur-Telgen, P. Van der Valk, J. Van der Palen (Enschede, Netherlands)
| |
To study the correlation of cardiopulmonary exercise test parameters with BODE index and severity of COPD
S. Chaurasia, T. Dhamgaye, R. Waghmare (Pune, India)
|  |
Changes in quality of life as assessed by St. Georges respiratory questionnaire (SGRQ) and COPD assessment test (CAT) and spirometric indices in patients with smoker-COPD(S-COPD) and non-smoker-COPD(NS-COPD) after 1 year of follow up
J. Londhe, B. Brashier, V. Das, K. Pyasi, S. Madas, S. Juvekar, S. Salvi, P. Barnes (Pune, India; London, United Kingdom)
| |